Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm, Pilot of Neoadjuvant Checkpoint Inhibition Followed by Adjuvant Checkpoint Inhibition in Children and Young Adults With Recurrent or Progressive High Grade Glioma (HGG)

NCT04323046 is registered in ClinicalTrials.gov with Sabine Mueller, MD, PhD as lead sponsor.

NCT NCT04323046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04323046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm, Pilot of Neoadjuvant Checkpoint Inhibition Followed by Adjuvant Checkpoint Inhibition in Children and Young Adults With Recurrent or Progressive High Grade Glioma (HGG)
Lead sponsor
Sabine Mueller, MD, PhD
Phase
Phase 1
Overall status
Active, not recruiting
Start date
October 2, 2020
Completion date
June 30, 2028
Enrollment
9 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, grade iii glioma, malignant glioma, recurrent glioblastoma, recurrent grade iii glioma, recurrent malignant glioma